I hope this works, I have been trying to make this new entry for an hour and it keeps giving me error messages.
Brigitt asked her OBGYN ONC a bunch of questions and we thought they should be here
Q. What is the likelihood that I'll get choriocarcinoma again with
A. Chorio would be the result of one of two situations:
1. Recurrence from the original chorio. This is highly unlikely since
recurrence did not happen within 24months of the original chorio. Likelihood of
recurrence after 24 months is about 1/1000
2. New chorio situation. In this case, the odds of getting chorio are the
same as before (approximately 1/160,000)
Q. Have you had patients who had chorio after full
term birth and then had another child?
A. Yes. They had normal
Q. Is there any way to determine during pregnancy
that chorio is present?
Do any special tests need to be done throughout
A. Risks of investigative procedures to
determine chorio are not worth taking, especially with the low likelihood of
recurrence (e.g. risk of X-rays on a pregnancy).
Q. What are symptoms of chorio during pregnancy?
A. Usually the symptoms of chorio manifest themselves when the chorio has
spread (e.g. lungs, liver, brain). No special symptoms exist
Q. If a full term birth occurs, what is protocol for chorio checks?
Is there preventative measures that will take place (e.g. methotrexate) after
birth? How soon will HcG test identify chorio after birth?
If there is a history of chorio, your OBGYN can order a pathology of the
placenta to ensure that there is no chorio present. Otherwise, a standard hcg
test 4 weeks after delivery would be advised (hcg may still be present within 4
weeks after a normal birth)
Q. Does chorio metastatis occur during pregnancy or afterwards if
chorio is suspected?
Tough to say.
Q. If chorio recurs, what is response/success rate if second round of
EMACO is required?
A. Response/success rate of EMACO would be the
same if it's a new chorio case. If the chorio is a result of a recurrence of the
original chorio, EMACO's success rate will be reduced by 10%